These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 32848776)

  • 1. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention.
    Hussman JP
    Front Pharmacol; 2020; 11():1169. PubMed ID: 32848776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
    Solimani F; Meier K; Ghoreschi K
    Eur J Immunol; 2021 May; 51(5):1071-1075. PubMed ID: 33675065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.
    Futosi K; Fodor S; Mócsai A
    Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil cell surface receptors and their intracellular signal transduction pathways.
    Futosi K; Fodor S; Mócsai A
    Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Sallenave JM; Guillot L
    Front Immunol; 2020; 11():1229. PubMed ID: 32574272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
    Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
    Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    bioRxiv; 2020 Nov; ():. PubMed ID: 33140051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of coronavirus-19 disease.
    Borczuk AC; Yantiss RK
    J Biomed Sci; 2022 Oct; 29(1):87. PubMed ID: 36289507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19.
    Melero I; Villalba-Esparza M; Recalde-Zamacona B; Jiménez-Sánchez D; Teijeira Á; Argueta A; García-Tobar L; Álvarez-Gigli L; Sainz C; Garcia-Ros D; Toledo E; Abengozar-Muela M; Fernández-Alonso M; Rodríguez-Mateos M; Reina G; Carmona-Torre F; Quiroga JA; Del Pozo JL; Cross A; López-Janeiro Á; Hardisson D; Echeveste JI; Lozano MD; Ho LP; Klenerman P; Issa F; Landecho MF; de Andrea CE
    Chest; 2022 Nov; 162(5):1006-1016. PubMed ID: 35714708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
    Zhu Y; Chen X; Liu X
    Front Immunol; 2022; 13():838011. PubMed ID: 35309344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
    Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho AF; Maes M; Walder K; Berk M
    Life Sci; 2020 Oct; 258():118166. PubMed ID: 32739471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
    Jalloh S; Olejnik J; Berrigan J; Nisa A; Suder EL; Akiyama H; Lei M; Tyagi S; Bushkin Y; Mühlberger E; Gummuluru S
    bioRxiv; 2022 Mar; ():. PubMed ID: 35378756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.